Regulating Urine pH Levels to Alleviate Chronic Joint Pain
WithdrawnPhase 1NCT01421160
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study aims to determine the causal relationship between regulating urine pH levels between 7.0 and 7.5 and decreasing chronic joint pain. The investigators hypothesize that maintenance of an alkaline urinary pH will result in a decrease in personally reported levels of chronic joint pain using a citrate treatment regimen.
Study details
- Official title
- A Pilot Study to Assess the Effects of Regulating Urine pH Levels for Alleviating Chronic Joint Pain
- Conditions
- Interventions
- Drug: sodium citrate and citric acid
- Sponsor
- Texas Tech University Health Sciences Center, El Paso
- Start date
- 2011-07
- Primary completion
- 2012-03
- Sex
- All
- Age range
- from 21 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Presence of joint pain of perceived inflammatory and non-inflammatory origin for more than six months. More specifically: * Subjects with osteoarthritis (OA) of the knee will be preferred for inclusion in this study. * Subjects with other joint pain history will be included pursuant on approval from Dr. Miller or Dr. Pema. 2. Age 21 to 80 years old and otherwise in good health (excluding the joint pain). 3. Able to understand and comply with the assigned urine alkalinization instructions. 4. Has a working and reliable telephone number for continued contact as necessary during the study. 5. Ability to obtain X-rays of the affected joint. Imaging of the painful joint will be necessary at the beginning of the study for baseline considerations; if images from the last 6 months are available, no new imaging would be necessary. 6. Ability to obtain lab tests (Complete Blood Count and Comprehensive Metabolic Panel) or can obtain documentation of recent lab tests that have been taken within one month prior to enrollment. 7. Ability to obtain lab tests at 3 and 6 months during participation in the study. Exclusion Criteria: 1. Presence of joint pain with known joint osseous changes. 2. Pregnant or lactating women will not be enrolled in the study. 3. Positive medical history of: * Diabetes * Neuropathies * Gout * Psychiatric diseases and conditions, including anxiety, depression, PTSD, distress * Psychosocial abnormalities * Dementia or other memory disturbances * Alcoholism or substance abuse * Renal failure and/or abnormal renal function (kidney disease or dysfunction). Specifically, Creatinine (Creat) values that are over 1.2mg/dL and Urea Nitrogen (BUN) values that are over 22mg/dL are considered abnormal. * No history of cardiovascular disease, intestinal angina or arrhythmias * No history of sodium restrictions * Pt. should not be taking medications which produce pain such as angiotensin converting enzyme (ACE) inhibitors and Statins (Lisinopril, Quinapril, Ramipril) 4. Does not have reliable telephone communication. 5. Does not have the ability to obtain an X-ray and does not have the ability to obtain documentation of a recent X-ray within the last six months. 6. Does not have the ability to obtain lab tests (Complete Blood Count and Comprehensive Metabolic Panel) and does not have the ability to obtain documentation of recent lab tests that have been taken within one month prior to enrollment. 7. Does not have the ability to obtain l…
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01421160